As of 2025-10-15, the Intrinsic Value of Biophytis SA (ALBPS.PA) is -2.25 EUR. This ALBPS.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.14 EUR, the upside of Biophytis SA is -1,663.65%.
Based on its market price of 0.14 EUR and our intrinsic valuation, Biophytis SA (ALBPS.PA) is overvalued by 1,663.65%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.25 - -2.25 | -2.25 | -1,663.65% |
| P/E | (2.81) - (3.36) | (2.96) | -2150.3% |
| DDM - Stable | (2.03) - (6.01) | (4.02) | -2889.6% |
| DDM - Multi | (1.52) - (3.86) | (2.22) | -1638.9% |
| Market Cap (mil) | 3.38 |
| Beta | 0.03 |
| Outstanding shares (mil) | 23.43 |
| Enterprise Value (mil) | 10.86 |
| Market risk premium | 5.82% |
| Cost of Equity | 14.95% |
| Cost of Debt | 5.00% |
| WACC | 7.19% |